Carlsbad, CA, United States of America

Zachary Engelder

This inventor holds 1 USPTO granted patent. Top assignee: Radiance Therapeutics, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Zachary Engelder in Brachytherapy

Introduction

Zachary Engelder is an accomplished inventor based in Carlsbad, CA (US). He has made significant contributions to the field of brachytherapy, particularly through his innovative designs and systems. His work focuses on enhancing the application of beta radiation for targeted tissue treatment.

Latest Patents

Zachary Engelder holds a patent for a "System for brachytherapy," which includes single-use brachytherapy systems designed for the application of beta radiation to target tissues. This innovative system features a cap that allows for the insertion of a radionuclide brachytherapy source (RBS) and a handle that can be removed from the cap. Once the handle is disengaged, the system becomes unusable for its original purpose unless repaired, ensuring safety and efficacy in its application.

Career Highlights

Zachary is currently employed at Radiance Therapeutics, Inc., where he continues to develop and refine his innovative approaches to brachytherapy. His work is pivotal in advancing treatment options for patients requiring targeted radiation therapy.

Collaborations

Zachary collaborates with notable colleagues, including Laurence J. Marsteller and James A. Fazio. Their combined expertise contributes to the ongoing development of effective therapeutic solutions in the field of radiation treatment.

Conclusion

Zachary Engelder's contributions to brachytherapy through his innovative patent and work at Radiance Therapeutics, Inc. highlight his commitment to improving patient care in radiation therapy. His advancements in single-use systems represent a significant step forward in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…